Adiponectin for treating pulmonary disease
OwnerKounori Kotosai, Kazuyoshi Kirima +3inventors
InventorsKounori Kotosai, Kazuyoshi Kirima, Keiko Karasutani, Yasukazu Ohmoto, Yoichi Yabuuchi
Life of this patent
Estimating the term…
Abstract
The present invention provides an agent for inhibiting alveolar airspace enlargement containing adiponectin or an agent for inhibiting alveolar wall destruction containing adiponectin. The pulmonary disease therapeutic agents of the present invention are highly safe drugs that possess an excellent effect of decreasing the deterioration of the pulmonary function, such as airflow limitation, and exhibit an extremely high effect of treating pulmonary disease accompanied by irreversible deterioration in pulmonary function, with fewer adverse side effects such as nausea, vomiting and gastric acid secretion.
Claims4
An agent for inhibiting alveolar airspace enlargement, comprising adiponectin.
An agent for inhibiting alveolar wall destruction, comprising adiponectin.
Dependencies are inferred from the claim text.